全球对GLP-1减肥药的使用日益增长，正推动消费者转向更注重营养的选择，为新西兰的高端食品生产商创造新的出口机会。
The growing global use of GLP-1 weight-loss drugs is pushing consumers toward more nutrition-conscious choices, creating new export opportunities for New Zealand's premium food producers.
GLP-1减肥药在全球的快速普及正在重塑消费者的饮食习惯，新西兰出口商表示，这一转变为该国的高端食品行业打开了新机遇。行业人士称，使用该药物的患者往往摄入的食物份量更小，并倾向于选择高质量、营养密集的食品，而非加工食品。
The rapid global rise of GLP-1 weight-loss medications is reshaping consumer eating habits, and New Zealand exporters say that shift is opening fresh opportunities for the country's premium food sector. Industry figures say patients using the drugs tend to eat smaller portions and favor higher-quality, nutrient-dense foods over processed alternatives.
长期以草饲乳制品、肉类和园艺产品出口闻名的新西兰农场主和种植者，正将其产品定位以满足这一需求。出口商表示，富含蛋白质和营养密集的高端食品对希望在整体摄食量减少的情况下保持肌肉质量和营养平衡的GLP-1使用者越来越有吸引力。
New Zealand farmers and growers, long known for grass-fed dairy, meat and horticultural exports, are positioning their products to meet that demand. Exporters say premium, protein-rich and nutrient-dense foods are increasingly attractive to GLP-1 users seeking to maintain muscle mass and nutritional balance while eating less overall.
分析人士称，即使传统的大宗商品出口量因其他地区饮食变化而受到压力，这一趋势仍可能支撑新西兰高价值出口品类的需求。行业组织正密切关注GLP-1市场，将其视为全球食品需求的结构性转变，而非短期潮流。
Analysts say the trend could support demand for New Zealand's higher-value export categories even as traditional bulk commodity volumes face pressure from changing diets elsewhere. Industry groups are watching the GLP-1 market closely, viewing it as a structural shift in global food demand rather than a short-term fad.